Phage-assisted continuous evolution of proteases with altered substrate specificity
Proteases are promising therapeutics to treat diseases such as hemophilia which are due to endogenous protease deficiency. Here the authors use phage-assisted continuous evolution to evolve a variant TEV protease with altered target peptide sequence specificities.
Guardado en:
Autores principales: | Michael S. Packer, Holly A. Rees, David R. Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08222d2b844046fe8d313002c7e42c08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Disulfide-compatible phage-assisted continuous evolution in the periplasmic space
por: Mary S. Morrison, et al.
Publicado: (2021) -
Improved pyrrolysine biosynthesis through phage assisted non-continuous directed evolution of the complete pathway
por: Joanne M. L. Ho, et al.
Publicado: (2021) -
Evolutionary Selection on Barrier Activity: Bar1 Is an Aspartyl Protease with Novel Substrate Specificity
por: Stephen K. Jones, et al.
Publicado: (2015) -
Mycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit different substrate specificities.
por: Yoann Personne, et al.
Publicado: (2013) -
Substrate profiling of tobacco etch virus protease using a novel fluorescence-assisted whole-cell assay.
por: George Kostallas, et al.
Publicado: (2011)